Exhaled nitric oxide in interstitial lung diseases

被引:27
|
作者
Cameli, P. [1 ]
Bargagli, E. [1 ]
Refini, R. M. [1 ]
Pieroni, M. G. [1 ]
Bennett, D. [1 ]
Rottoli, P. [1 ]
机构
[1] Le Scotte Hosp, Dept Med & Surg Sci & Neurosci, Resp Dis & Lung Transplantat Sect, Siena, Italy
关键词
Nitric oxide; Idiopathic pulmonary fibrosis; Non-specific interstitial pneumonia biomarker; Oxidative stress; Nitrosative stress; IDIOPATHIC PULMONARY-FIBROSIS; ALVEOLAR CONCENTRATION; NITROSATIVE STRESS; INFLAMMATION; SYNTHASE; SILICA; FLUX;
D O I
10.1016/j.resp.2014.03.011
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Nitric oxide (NO) is a biomarker of nitrosative stress, which is involved in the pathogenesis of idiopathic interstitial pneumonias (IIP). This study evaluates exhaled NO levels in IIP patients and relates alveolar concentrations of NO (Calv(NO)) to pulmonary function test (PFT) and 6-minute walking test (6MWT) parameters. We measured fractional exhaled nitric oxide (FeNO), Calv(NO) and maximum conducting airway wall flux (J'aw(NO)) in 30 healthy subjects and 30 patients with IIP (22 idiopathic pulmonary fibrosis and 8 idiopathic non-specific interstitial pneumonias). IIP patients had higher FeNO at flow rates of 50-100-150 ml/s and higher Calv(NO) levels than healthy controls (p < 0.0001). Calv(NO) was significantly correlated with 6-minute walking distance (p < 0.0001), recovery time (p < 0.0005), TLC (p < 0.001), PVC (p = 0.01) and TLCO (p < 0.01). IIP patients showed abnormal nitric oxide production, probably due to lung fibrosis and oxidative-mediated lung injury. Calv(NO) was correlated with PFT and 6MWT parameters and is proposed as a potential biomarker of lung fibrosis and exercise tolerance. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [21] Exhaled nitric oxide in diagnosis and management of respiratory diseases
    Dilka, Eugerta
    Cuko, Armela
    Argjiri, Dhimiter
    Kore, Roland
    Beli, Jeta
    Shehu, Elenka
    Tashi, Eritjan
    Ndreu, Edlira
    Nushi, Esmeralda
    Tanku, Arben
    Simaku, Artan
    Kapisyzi, Perlat
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [22] EXHALED NITRIC OXIDE IN CHILDREN WITH CONGENITAL HEART DISEASES
    Omercahic-Dizdarevic, A.
    Dinarevic, S. Mesihovic
    ACTA PAEDIATRICA, 2011, 100 : 24 - 24
  • [23] Exhaled nitric oxide and carbon monoxide in respiratory diseases
    Antus, Balazs
    Horvath, Ildiko
    JOURNAL OF BREATH RESEARCH, 2007, 1 (02)
  • [24] Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
    Maniscalco, Mauro
    Fuschillo, Salvatore
    Mormile, Ilaria
    Detoraki, Aikaterini
    Sarnelli, Giovanni
    de Paulis, Amato
    Spadaro, Giuseppe
    Cantone, Elena
    CELLS, 2023, 12 (21)
  • [25] Exhaled Nitric Oxide in Diagnosis and Management of Respiratory Diseases
    Dilka, Eugerta
    Tashi, Eritian
    Cuko, Armela
    Beli, Jeta
    Shehu, Elenka
    Kore, Roland
    Argjiri, Dhimitraq
    Tanka, Arben
    Ndreu, Edlira
    Nushi, Esmeralda
    Kapisyzi, Perlat
    CHEST, 2013, 144 (04)
  • [26] Exhaled nitric oxide in diagnosis and management of respiratory diseases
    Abba, Abdullah A.
    ANNALS OF THORACIC MEDICINE, 2009, 4 (04) : 173 - 181
  • [27] Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
    Kozij, Natalie K.
    Granton, John T.
    Silkoff, Philip E.
    Thenganatt, John
    Chakravorty, Shobha
    Johnson, Sindhu R.
    CANADIAN RESPIRATORY JOURNAL, 2017, 2017
  • [28] Exhaled nitric oxide: A new lung function test
    Barnes, PJ
    Kharitonov, SA
    THORAX, 1996, 51 (03) : 233 - 237
  • [29] Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
    Kozij, Natalie K.
    Granton, John T.
    Silkoff, Philip E.
    Thenganatt, John
    Chakravorty, Shobha
    Johnson, Sindhu R.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [30] Markers of lung disease in exhaled breath: Nitric oxide
    Choi, J
    Hoffman, LA
    Rodway, GW
    Sethi, JM
    BIOLOGICAL RESEARCH FOR NURSING, 2006, 7 (04) : 241 - 255